Request Legal Help Now - Free
Advertisement
 
Home Page >> Legal News Articles >> Drugs/Medical

Legal News Articles - Drugs/Medical

One Year after Blockbuster Risperdal Gynecomastia Award, Lawsuits Now Top 20,000

One Year after Blockbuster Risperdal Gynecomastia Award, Lawsuits Now Top 20,000 July 11, 2017. By Gordon Gibb.
Philadelphia, PA: On the day that the Philadelphia Court of Common Pleas is holding a status update and discussion on the Risperdal lawsuit file, (July 11, 2017) it’s instructive to look rearwards a year and a week to July 1, 2016 when a $70 million verdict was delivered by a Pennsylvania state court jury favoring the plaintiff in a Risperdal gynecomastia lawsuit.
Read [ One Year after Blockbuster Risperdal Gynecomastia Award, Lawsuits Now Top 20,000 ]

Mesothelioma Lawsuit Revived in California

Mesothelioma Lawsuit Revived in California July 10, 2017. By Gordon Gibb.
Los Angeles, CA: A mesothelioma victim who alleges her asbestos disease was caused by exposure to her late husband’s work clothes has seen her asbestos mesothelioma lawsuit revived after it was originally lost to a summary judgement ruling in favor of the defendant.
Read [ Mesothelioma Lawsuit Revived in California ]

Power Morcellation Cancer Warning One Year Too Late for Doctor

Power Morcellation Cancer Warning One Year Too Late for Doctor July 10, 2017. By Jane Mundy.
:Washington, DC: Dr. Amy Reed, a physician and mother of six had surgery for uterine fibroids with a power morcelletor one year before the FDA first warned about the risk of power morcellators spreading cancer. Dr. Reed died from cancer in May—she was 44 years old.
Read [ Power Morcellation Cancer Warning One Year Too Late for Doctor ]

Monsanto Loses Bid to Delay Placement of Roundup on Unflattering List

Monsanto Loses Bid to Delay Placement of Roundup on Unflattering List July 8, 2017. By Gordon Gibb.
Fresno, CA: Monsanto has been trying very hard to keep the primary ingredient in Monsanto Roundup off a list of cancer-causing chemicals maintained by the state of California. Monsanto maintains that glyphosate, the key ingredient to its popular weed killer, is perfectly safe and does not cause cancer, a fact disputed by the International Agency for Research on Cancer. However, Monsanto Roundup causes cancer will indeed, migrate to a list maintained by the Office of Environmental Health Hazard Assessment after the California Supreme Court upheld a lower court ruling.
Read [ Monsanto Loses Bid to Delay Placement of Roundup on Unflattering List ]

Second Bellwether Xarelto Lawsuit Goes to Defendant, All Eyes on Third

Second Bellwether Xarelto Lawsuit Goes to Defendant, All Eyes on Third July 8, 2017. By Gordon Gibb.
New Orleans, LA: The second bellwether Xarelto lawsuit in multidistrict litigation over allegations of Xarelto bleedout in association with the new age blood thinner has gone, like the first, to the defendant. While this may prove disappointing to litigants alleging the anticoagulant is unsafe, there are still two more bellwether trials to roll out later this year, with some 15,000 cases in the federal multidistrict litigation pipeline housed in New Orleans. Additional cases are percolating at the state level in Philadelphia.
Read [ Second Bellwether Xarelto Lawsuit Goes to Defendant, All Eyes on Third ]

New Study Suggests Popular Heartburn Drugs Associated With a Higher Risk of Death

New Study Suggests Popular Heartburn Drugs Associated With a Higher Risk of Death July 7, 2017. By Deb Hipp.
St. Louis, MO: A new study suggests that some popular heartburn drugs known as proton pump inhibitors are associated with a higher risk of death.
Read [ New Study Suggests Popular Heartburn Drugs Associated With a Higher Risk of Death ]

Taxotere Hair Loss: Are Doctors Forthright with their Patients as to Risk?

Taxotere Hair Loss: Are Doctors Forthright with their Patients as to Risk? July 6, 2017. By Gordon Gibb.
Washington, DC: Many a Taxotere hair loss lawsuit asserts that the manufacturer of Taxotere (docetaxel), Sanofi, knew about the increased risk for permanent hair loss associated with its cancer drug, and yet downplayed the risk without revealing that competing products on the market were just as effective at treating cancer as Taxotere, but without the corresponding increased risk for permanent hair loss, or so it is alleged.
Read [ Taxotere Hair Loss: Are Doctors Forthright with their Patients as to Risk? ]

Concern over Rates of Depression amongst Propecia Sexual Dysfunction Patients

Concern over Rates of Depression amongst Propecia Sexual Dysfunction Patients July 6, 2017. By Gordon Gibb.
Milan, Italy: Propecia finasteride has, for some time, been employed as an effective solution to male pattern baldness and hair loss, a condition that usually hits most men at middle age but in rare cases can appear in men as young as 18. However, for many consumers Propecia side effects have combined to not only spoil the party on top of their once-bald pate, but to also serve as the foundation for panic between the sheets. In rare, but growing cases use of finasteride for hair growth has led to Propecia impotence.
Read [ Concern over Rates of Depression amongst Propecia Sexual Dysfunction Patients ]

Smith & Nephew Birmingham Hip Resurfacing Lawsuit Filed

Smith & Nephew Birmingham Hip Resurfacing Lawsuit Filed July 5, 2017. By Lucy Campbell.
Santa Clara, CA: Smith & Nephew is the latest hip replacement maker to face a lawsuit over defective design resulting in personal injury. The complaint was filed by a woman who alleges she developed metallosis, or metal blood poisoning, after having a Smith and Nephew 50mm Birmingham Resurfacing femoral head, and a 56mm Birmingham Resurfacing acetabular cup surgically implanted.
Read [ Smith & Nephew Birmingham Hip Resurfacing Lawsuit Filed ]

Eli Lilly & Co. Testosterone Bellwether Trials Scheduled for 2018

Eli Lilly & Co. Testosterone Bellwether Trials Scheduled for 2018 July 4, 2017. By Gordon Gibb.
Chicago, IL: AbbVie Inc., the makers of AndroGel, have garnered the lion’s share of attention (and the highest proportion of lawsuits) in the testosterone side effects MDL to date. However Eli Lilly and Co. (Lilly), the manufacturer of Axiron, is the subject of renewed focus after the federal judge in Illinois overseeing multidistrict litigation last month selected the first two bellwether cases that will go to trial next year (In re: Testosterone Replacement Therapy Products Liability Litigation, Case No: 1:14-cv-01748, in the US District Court for the Northern District of Illinois).
Read [ Eli Lilly & Co. Testosterone Bellwether Trials Scheduled for 2018 ]

Page: 1  -  3  4  5  6  7  8  9  -  10»  -  100»  -  124   Next»
Request Legal Help Now! - Free